INDBInternet News Database 2.5 Updated 1 min ago · 282 sources Show or hide images Light or dark

New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- Treatment with both elafibranor (Iqirvo) and seladelpar (Livdelzi) led to alkaline phosphatase (ALP) normalization in the vast majority of patients with primary biliary cholangitis (PBC) who had elevated ALP levels after an incomplete...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis

    (MedPage Today) -- Treatment with both elafibranor (Iqirvo) and seladelpar (Livdelzi) led to alkaline phosphatase (ALP) normalization in the vast majority of patients with primary biliary cholangitis (PBC) who had elevated ALP levels after an incomplete...

Comments

Comments need JavaScript.